About

Novo Nordisk A/S is a Danish pharmaceutical company that specializes in diabetes and obesity care. Its 2025 sales grew 6.4% to DKK 309 billion (about $43 billion), led by 31% growth in obesity care. It is a global leader in diabetes, though its diabetes value market share slipped to 31.6% in the 12 months to Q3 2025.

Awards

Hillerød, DK - Lighthouse award in Productivity

Sep 2020

Between 2017 and 2022 the device manufacturing and sourcing unit was asked to cut unit cost by 46%, absorb 160% volume growth and handle a product mix expanding from 5 to 25 variants. A digital lighthouse was built to meet that brief and to seed a corporate programme scaling the playbook across 15 sites.